tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market
Advertisement

Verona Pharma (VRNA) Technical Analysis

Compare
872 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 5.16, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 98.76, while Verona Pharma Plc’s (VRNA) share price is $104.9, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 89.21, while Verona Pharma Plc’s (VRNA) share price is $104.9, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Jul 22, 2025, 06:46 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
104.15
104.46
104.68
104.99
105.21
105.52
105.74
Fibonacci
104.46
104.66
104.79
104.99
105.19
105.32
105.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Jul 22, 2025, 06:46 PM
Period
Simple
Exponential
MA5
104.82Buy
104.46Buy
MA10
103.01Buy
102.57Buy
MA20
98.28Buy
98.76Buy
MA50
87.11Buy
89.21Buy
MA100
75.51Buy
78.28Buy
MA200
59.88Buy
62.00Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 102.57, while Verona Pharma Plc’s (VRNA) share price is $104.9, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 78.28, while Verona Pharma Plc’s (VRNA) share price is $104.9, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $104.9 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 87.11, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $104.9 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 75.51, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $104.9 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 59.88, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Jul 22, 2025, 06:46 PM
Name
Value
Implied Action
RSI (14)
70.69
Sell
STOCH (9,6)
80.39
Sell
STOCHRSI (14)
98.19
Sell
MACD (12,26)
5.16
Sell
ADX (14)
30.39
Neutral
Williams %R
-2.14
Sell
CCI (14)
75.27
Neutral
ATR (14)
2.62
-
Ultimate Oscillator
40.74
Neutral
ROC
10.91
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 70.69, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 30.39, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 75.27, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 10.91, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 70.69, which suggests VRNA is a Sell.
      What is VRNA’s MACD?
      VRNA’s MACD is 5.16, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 104.82, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 98.28, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 87.11, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 59.88, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -2.14, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 75.27, which suggests VRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis